Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3365368 | Tgfbeta1-Binding Immunoglobulins And Use Thereof | SCHOLAR ROCK, INC. | Feb 16, 2024 |
EP2981822 | Compositions And Methods For Growth Factor Modulation | SCHOLAR ROCK, INC. | Jun 1, 2021 |
EP2956483 | Therapeutic And Diagnostic Target For Cancer Comprising Dll3 Binding Reagents | BOEHRINGER INGELHEIM INTERNATIONAL GMBH | Feb 26, 2021 |
Patent Number | Grant Date | Title | Total Oppositions |
---|---|---|---|
EP3296395 | Jun 19, 2024 | Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion | 1 |
EP2679681 | Nov 15, 2023 | Fc Riib-Specific Fc Antibody | 1 |
EP3320773 | Oct 11, 2023 | Non-Human Animal Having Human Cd3 Gene Substituted For Endogenous Cd3 Gene | 1 |
EP3199952 | Nov 2, 2022 | Method For Measuring Reactivity Of Fviii | 2 |
EP2578231 | Oct 26, 2022 | Antitumor T Cell Response Enhancer | 1 |
EP3330279 | Apr 6, 2022 | Method For Purifying Composition Comprising Antibodies With Anionic Polymer | 1 |
EP3130606 | Oct 13, 2021 | Immunoactivating Antigen-Binding Molecule | 2 |
EP3056568 | Sep 15, 2021 | Methods For Controlling Blood Pharmacokinetics Of Antibodies | 2 |
EP3342786 | Jun 23, 2021 | Anti-Dll3 Antibody | 2 |
EP3378486 | Mar 3, 2021 | Stabilized Antibody-Containing Liquid Formulations | 5 |
Feel free to send us a message here and we will get back to you